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Welcome to the RBPome
RNA has consistently broken dogmas, owing to its
multitude of unexpected functions. However, RNA does
faithfully adhere to one rule: it always functions through
interactions with proteins. The studies in this issue focus
on the rapidly expanding repertoire of diverse RNA–
protein interactions [1] and their functional roles and
physiological consequences, both from the perspective
of RNA-binding proteins (RBPs) and from the vantage
point of RNAs - coding and noncoding - that interface
with RBPs.
RNA-protein interactions are fascinating for many
reasons, one being their role in evolution - from the earliest
life forms to the most complex organisms (examples
reviewed in [2-4]). For example, the interactions between
pre-mRNA and proteins fine-tune alternative splicing in a
manner that can gradually create new protein functional-
ities without the need to create additional genes and
without affecting existing proteins [4-6]. Moreover, there
has been an emergence of numerous noncanonical RBPs
(that is, proteins not previously thought to function as
RBPs) that are influenced by interactions with RNA
transcripts coding and noncoding alike [7,8]. In fact,
genome-wide footprinting articles in this issue [9-11]
demonstrate a vast and diverse landscape of RNA–RBP
complexes that play key regulatory roles.
With recent advances in technology, together with
powerful combined experimental and computational
developments, we have witnessed unprecedented new
insights into the diverse and dynamic interactions that
occur between RNA and proteins. These range from
new functions of well-established RBPs to the molecular
sequences and structures harbored in RNA that drive
interactions with proteins. Despite this great progress,
the present issue of Genome Biology demonstrates that
there are still unresolved aspects of RBP biology.
Technology opening up new horizons of the
RBPome
A major challenge in understanding RNA–protein inter-
actions has been to remove non-specific abundant RNAs
when mapping protein-binding sites in low-abundant
RNAs. For instance, in order to understand how tissue
specificity of splicing is determined, it was important to
identify protein-binding sites on pre-mRNAs without
contamination from mRNAs or ribosomal RNAs. This
was achieved with the UV crosslinking and immuno-
precipitation (CLIP) method, which employs stringent
purification steps to identify specific binding sites to the
exclusion of non-specific events [12].
As advances were made in CLIP technology [13,14],
integrative computational approaches were developed to
combine CLIP with genome-wide studies of alternative
splicing to define regulatory maps for specific RBPs.
These maps unraveled the position-dependent principles
that were capable of predicting the functional binding
sites of RBPs [15-17]. Moreover, the regulatory elements
positioned around alternative exons were used to derive
a splicing code with a capacity to predict tissue-specific
splicing with a reasonable accuracy [18,19].
Technology developed to better understand RNA–
protein interactions is not limited to CLIP, but is also
maturing on several additional fronts [11,14]. Indeed,
presented in this issue are a number of novel genome-
wide experimental and analysis techniques that yield
new insights into RBPology [9,10,20-25]. RNA pull-
downs (also known as RIP-seq) and RNA-footprinting
methods are revealing key RBP interactions that do not
fit the mold of classic RBPs. Technologies will therefore
need to advance further if we are to better understand
the interplay of noncoding transcripts and RBPs. Why
are long noncoding RNA (lncRNA) transcripts alter-
natively spliced by RBPs like their translated mRNA
counterparts? Can lncRNAs serve as decoys, scaffolds or
allosteric effectors of RBPs [26]?
Future studies will need to focus on additional tech-
nologies in order to identify the specific sequences and
structures of RBP–RNA complexes on a larger scale. For
example, new methods that determine the genome-wide
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in achieving this goal [27,28]. The many other key
aspects of the RBPome that still remain to be solved
include understanding the combinatorial interactions of
proteins on a given RNA substrate. Can multiple inter-
actions provide combinatorial control? Methods to
understand the structure and interactions of RBPs on
full-length RNAs will be needed in the future.
New RNA species detected by high-throughput
sequencing
The ability to detect low-abundant RNAs by using
high-throughput sequencing has led to the discovery of
thousands of noncoding RNAs (discussed in [29]). One
facet of the noncoding transcriptome that has been of in-
tensive research focus is lncRNAs. As perhaps expected,
lncRNAs have been found to break the rules and form
numerous noncanonical interactions with proteins such as
chromatin regulatory complexes, cohesins and transcrip-
tion factors (see, for example, [30-32]). Moreover, lncRNAs
have been shown to influence the regulatory dynamics of
small RNAs through sponging [33] and other mechanisms.
However, it is not known whether lncRNA–protein inter-
actions are generally required to mediate the functions of
lncRNAs or, vice versa, whether lncRNAs modulate RBPs.
The advent of new techniques that can identify RNA–
DNA and RNA–protein interactions are revealing a new
regulatory layer of lncRNAs. These techniques, which
include CHART [34], RAP [35] and ChOP [36], are con-
ceptually similar to ChIP. Instead of mapping DNA–
protein interactions, however, these methods determine
the localization of RNA on DNA and, moreover, enable
the study of proteins that interact with RNA at these
sites. Experiments of this nature will provide missing
clues into the regulatory principles of how lncRNAs
arrive at their target sites, the proteins they interact with
to get there and which sequences are specifically
required. Collectively, lncRNA–protein interactions
perhaps herald a new code for RNA localization around
the genome and how it influences local and distal
epigenetic aspects of nuclear architecture through these
interactions. This is an area certain to be of intense
development and research focus in the future.
New RNA modifications detected by high-
throughput sequencing
Modified ribonucleic bases have been an area of active
interest for over half a century. Yet recent genomic
sequencing technologies have expanded the modified
RNA space beyond classic tRNA and rRNA modifi-
cations to incorporate mRNA and lncRNA transcripts as
well (reviewed in [37,38]). The field of epitranscrip-
tomics is in its infancy, and many questions remain to
be answered. Why are these modifications so prevalent?
How do they influence RNA-binding interactions and
RNA structure? What is their function? Moreover, these
same questions also apply to the regulatory layers
formed by RNA editing [39]. Specifically, Levanon and
colleagues demonstrate that only a very small fraction of
sites edited by ADAR are conserved.
Understanding disease-causing mutations
Impact upon human disease is perhaps the most import-
ant new frontier in the study of the RBPome. We need
to use classic genetic approaches and population studies
to identify mutations in both RBPs and RNA substrates
themselves. Great progress has been made in finding
mutations in RBPs associated with disease risk, such as
the RBPs FUS and TDP-43 in amyotrophic lateral scler-
osis (reviewed in [40]). Yet more work will be needed to
understand what changes occur to RNA substrates in
disease and their effect on structure and function, al-
though progress in this area is already underway
(reviewed in this issue in [41]).
Several studies in this issue have taken on the challenge
of examining the intersection between the RBPome and
human disease. Mort, Mooney and colleagues identify
single-base mutations that affect the alternative splicing
of key regulatory mRNAs [25]. Kechavarzi and Janga
explore the dysregulation of RBP-encoding transcripts in
cancer and the resulting changes in protein interaction
networks [42]. Finally, Tuschl, Wessels and colleagues
use PAR-CLIP data to identify differential microRNA
targeting that is correlated with breast cancer subtypes
[43]. These types of studies are archetypical for nume-
rous future studies to understand the influence of the
RBPome on human health and disease.
The next challenge will be to integrate DNA and RNA
biology to understand how the various transcriptional
and post-transcriptional mechanisms cooperate to or-
chestrate gene expression. This knowledge will be cru-
cial in order to benchmark the mutations that cause
disease by changing gene expression.
Cometh the hour, cometh the special issue
The field’s rapid diversification and growth, together
with an increasing impact on human health, makes for
perfect timing for a Genome Biology issue focused on
the RBPome!
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